Researchers are testing the effectiveness of Metformin to help improve daily living for individuals with Fragile X Syndrome (FXS)
In previous studies, Metformin has been shown to improve certain symptoms and difficulties experienced by individuals with FXS, We are looking for participants in a study that will determine the safety and benefits of Metformin for these individuals.
Who can participate? Individuals aged 6-35 who have been diagnosed with FXS (and fit the Inclusion/Exclusion critera).
What will participants do? Participate in a 4-month study which includes 3 clinic visits and 5 phone calls while taking Metformin orally. Complete various tasks, questionnaires and examinations by a physician or researcher. Participants will also have blood drawn, as well as urine and stool samples taken.